Myocor Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Myocor General Information
Description
Developer of devices to treat mitral valve insufficiency and congestive heart failure. The company develops medical devices that alter the physiology of the heart failure disease process and help clinical outcomes for late stage heart failure patients. The firm offers the Coapsys, which uses pads and a string passed through the heart with tension applied to reshape an enlarged heart and force a leaky mitral valve to work better.
Contact Information
Website
www.myocor.comCorporate Office
- 13300 67th Avenue North
- Osseo, MN 55311
- United States
Corporate Office
- 13300 67th Avenue North
- Osseo, MN 55311
- United States
Myocor Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 31-Dec-2008 | Completed | Startup | |||
5. Later Stage VC | 05-May-2008 | Completed | Generating Revenue | |||
4. Later Stage VC (Series D) | 21-Dec-2004 | Completed | Generating Revenue | |||
3. Later Stage VC (Series C) | 03-May-2001 | Completed | Generating Revenue | |||
2. Early Stage VC | 08-Jan-2001 | $11M | $11.5M | Completed | Startup | |
1. Angel (individual) | 01-Apr-1997 | $500K | $500K | Completed | Startup |
Myocor Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D | ||||||||
Series C | ||||||||
Series B | 349,700 | $0.010000 | $20 | $10 | $6.8 | 5.73% | ||
Series A | 445,400 | $0.010000 | $9 | $4.5 | $4.1 | 5.45% |
Myocor Patents
Myocor Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2003295380-A1 | Devices and methods for heart valve treatment | Inactive | 12-Nov-2002 | ||
EP-1560526-A2 | Devices and methods for heart valve treatment | Active | 12-Nov-2002 | ||
EP-1560526-B1 | Devices for heart valve treatment | Inactive | 12-Nov-2002 | ||
AU-2003202196-A1 | Devices and methods for heart valve treatment | Inactive | 09-Jan-2002 | ||
US-20070050022-A1 | Devices and methods for heart valve treatment | Inactive | 09-Jan-2002 | A61F2/2451 |
Myocor Former Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Affinity Capital Management | Venture Capital | Minority | ||
Alta Partners | Venture Capital | Minority | ||
Coral Group | Venture Capital | Minority | ||
IVP | Venture Capital | Minority | ||
Patricia Industries | PE/Buyout | Minority |
Myocor FAQs
-
When was Myocor founded?
Myocor was founded in 1996.
-
Where is Myocor headquartered?
Myocor is headquartered in Osseo, MN.
-
What industry is Myocor in?
Myocor’s primary industry is Therapeutic Devices.
-
Is Myocor a private or public company?
Myocor is a Private company.
-
What is Myocor’s current revenue?
The current revenue for Myocor is
. -
How much funding has Myocor raised over time?
Myocor has raised $60.2M.
-
Who are Myocor’s investors?
Affinity Capital Management, Alta Partners, Coral Group, IVP, and Patricia Industries are 5 of 9 investors who have invested in Myocor.
-
When was Myocor acquired?
Myocor was acquired on 31-Dec-2008.
-
Who acquired Myocor?
Myocor was acquired by Edwards Lifesciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »